Searchable abstracts of presentations at key conferences in endocrinology

ea0081p353 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Evaluating obesity among second and third age premature children

Jha R K , Chandra A K

Introduction: Premature newborns are defined as babies born before 37 weeks of pregnancy and after 22 weeks of pregnancy as a viability limit. This study aimed to analyse growth characteristics at the age of second and third age and the prevention of metabolic diseases that may occur in adult age at an early phase.Methods: This study was conducted as a retrospective cohort study between May 2021 and October 2021 in 18 different Outpatient Clinics in Patn...

ea0031p73 | Clinical practice/governance and case reports | SFEBES2013

Hypercalcaemia secondary to colecalcifrol administration in undiagnosed sarcoidosis

Aggarwal Naveen , Narayanan K R

A 32-year-old gentleman, of South-Asian origin was admitted with a 4-week history of abdominal pain, nausea and vomiting. He also had history of polyuria, polydipsia and weight loss over 6 weeks. Just prior to these symptoms he had been started on colecalciferol 20 000 units weekly by his GP for Vitamin D deficiency (25(OH) Vitamin D – 10.3 nmol/l (48–145)). On admission he had adjusted calcium of 4.52 mmol/l and acute kidney injury with his eGFR being 38 ml/min per ...

ea0031p101 | Clinical practice/governance and case reports | SFEBES2013

Hypercalcaemia as first presentation of sarcoidosis

Aggarwal Naveen , Narayanan K R

A 37-year-old gentleman was admitted following a GP referral for asymptomatic hypercalcaemia. His adjusted calcium was raised at 3.27 mmol/l while phosphate level was normal. The only past medical history was borderline hypertension which was being monitored in primary care. His PTH level was suppressed at 0.43 pmol/l l (1.1–5.5) while 25(OH) Vitamin D was normal at 71.6 nmol/l (48–145). Twenty-four hours urinary metadrenalines were normal. His full blood counts were...

ea0058p079 | Diabetes | BSPED2018

Maturity onset diabetes of the young (MODY): A report of 7 related and unrelated cases in a university hospital

Nambisan Aparna K R , Kapila Piyusha

Introduction: MODY is a group of monogenic disorders contributing to about 1% of diabetes due to a primary defect in the function of the beta cells of the pancreas. Although increasingly recognised, it is often misdiagnosed as type 1 or Type 2 Diabetes Mellitus(T2DM). We describe 7 cases of MODY of which 6 were genetically confirmed.Case reports: Siblings with loss of function mutation of ABCC8 gen. 2 brothers were diagnosed to have diabetes at 15 and 12...

ea0037gp.09.05 | Nuclear receptors and signalling | ECE2015

Neuroprotective effects of 17β-oestradiol: a therapeutic potential drug for Alzheimer's disease

Kumar Pardeep , Kale R K , Baquer N Z

Objectives: Alzheimer’s disease (AD) is the most common form of dementia in the elderly. AD is characterized by the presence of amyloid plaques which are formed from deposits of β-amyloid protein (Ab). These changes increase during menopausal condition in females when the level of oestradiol (E2) is decreased. The aim of the present study was to determine the effect of neuropeptide, neurokinin B (NKB) and amyloid beta fragment Aβ (25–35) on E<sub...

ea0037ep398 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Modulation of metabolic parameters and antioxidant enzymes in diabetic ageing female rat brains: beneficial role of metformin

Kumar Pardeep , Kale R K , Baquer N Z

Objective: The objective of this study was to investigate beneficial effects of metformin on membrane bound enzymes (monoamine oxidase, Na+K+ ATPse) and antioxidant enzymes (sueroxidase dismutase and glutathione S-transferases), lipid peroxidation, neurolipofuscin, and DNA degradation in diabetic aging female rats.Methods: Young (3 months) adult (12 months) and aged (24 months) rats will be diabetic by using alloxan monohyd...

ea0032p503 | Endocrine disruptors | ECE2013

Protective potential of 17-beta-estradiol on membrane linked functions in aging female rats: a behavioral, biochemical and ultrastructural study

Kumar Pardeep , Kale R K , Baquer N Z

Background: Alzheimer’s disease (AD) is the most common form of dementia in the elderly. AD is characterized by the presence of amyloid plaques which are formed from deposits of b-amyloid protein (Ab). These changes increase during menopausal condition in females when the level of estradiol is decreased.Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetyl...

ea0036oc4.8 | Oral Communications 4 | BSPED2014

Recombinant human GH in paediatric inflammatory bowel disease: short term effects on bone biomarkers and long term effects on bone and lean mass

Altowati M A , Shepherd S , McGrogan P , Russell R K , Wong S C , Ahmed S F

Background: Recombinant human GH (rhGH) may improve bone mass in paediatric inflammatory bowel disease (IBD).Objective: To investigate rhGH on bone and body composition in paediatric IBD.Method: Bone biomarkers were evaluated in 12 children, 11CD (10M), median age 14.4 year (8.9, 16.2) who received rhGH (0.067 mg/kg per day) as part of a 6 months RCT. Eight received rhGH for 24 months and had DXA evaluation. Results were reported a...

ea0027p10 | (1) | BSPED2011

A longitudinal study of pubertal growth in inflammatory bowel disease

Mason A , Russell R K , Bishop J , McGrogan P , MacIntyre H E , Ahmed SF

Background: Delayed puberty and related problems with growth and body image in Crohn’s disease (CD) and ulcerative colitis (UC) have rarely been quantified.Methods: A longitudinal prospective observational study of children with IBD who had anthropometric and puberty data at 0 and 6 months. Of 50 recruited, there were 15 boys (CDM) and 20 girls (CDF) with CD and ten boys (UCM) and five girls (UCF) with UC. The four groups had a median age at 0 month...

ea0025p11 | Bone | SFEBES2011

Bone turnover markers in patients on aminobisphosphonate therapy for osteoporosis

Crowley R K , Brady J J , Kilbane M , McKenna M J

Aminobisphosphonates impair osteoclast cell function and reduce bone remodelling rate. It has been speculated that atypical femoral fractures in patients on bisphosphonates are the result of impaired bone remodelling.The primary aim of this prospective study was to assess levels of bone remodelling in patients with osteoporosis on aminobisphosphonate therapy by measurement of bone turnover markers. The secondary aim was to assess the adequacy of concomit...